期刊文献+

玻璃体内注射曲安奈德治疗Coats病渗出性视网膜脱离

The treatment of intravitreous injection with triameinolone acetonide for Coats'disease with exudative retinal detachment
下载PDF
导出
摘要 目的观察玻璃体内注射曲安奈德(TA)治疗Coats病渗出性视网膜脱离的疗效。方法12例(12只眼)经眼底检查、荧光素眼底血管造影(FFA)和B超确定的Coats病引起的视网膜脱离患者接受玻璃体内注射40mg/1ml的TA0.1ml治疗,平均随访10.2个月,对比观察治疗前后患眼视力、眼压、视网膜复位情况。结果12只眼中10只眼视网膜复位,占83.3%,随访3个月2只眼因视网膜未完全复位,再次行玻璃体内注射TA;术后视力均有不同程度提高;2只眼眼压升高发生于用药后1周至2个月,经局部用β受体阻滞剂眼压控制正常;1只眼白内障发展。结论玻璃体内注射TA是治疗Coats病引起的渗出性视网膜脱离的有效手段。 Objective To observe the treatment of intravitreous injection with triameinolone aeetonide for Coats' disease with Exudative retinal detachment. Methods Coats'disease with external exudative retinopathy patients decided by checking the eyeground of 12 cases (12 eyes ), carrying out fundus fluorescence angiography ( FFA ) and B ultrasound check accept the treatment of injecting 40mg/lml TA0. lml into the vitreous body. Tracing down the treatment result of these patients 10.2 months for each one in average, and compare the eyes before the treatment with those after the treatment in the situations of sight, eye pressure, the restoration of retina. Results The retina of ten out of those twelve ill eyes have restored, which are 83.3%. after tracing down for 3 months, the retina of two ill eyes had not restored completely, so these two eyes accepted the injection of TA into the vitreous body again; after the operation, the sight of those ill eyes enhanced in different margins ; after 1 week to 2 months after the operation, the eye pressure of two eyes goes up. After partial β-receiver retarder control, they became normal; The catarael developed in 1 eye. Conclusion Intmvitreous injection with triameinolone acetonide for Coats'disease with exudative retinal detachment is one effective method.
出处 《临床眼科杂志》 2008年第4期308-310,共3页 Journal of Clinical Ophthalmology
关键词 COATS病 渗出性视网膜脱离 曲安奈德/治疗应用 Coats' disease Exudative retinal detachment Triamcinolone acetonide/therapeutic use
  • 相关文献

参考文献10

  • 1严密,刘谊,罗成仁,张军军,杨兰芬.Coats病的分型与年龄[J].中华眼底病杂志,1996,12(2):77-79. 被引量:23
  • 2李凤鸣,主编.眼科全书.北京:人民卫生出版社,2000:2244.
  • 3Morales AG. Coats'disease. Am J Ophthalmol, 1965,60: 855- 864.
  • 4Nucci P,Bandello F, Serafino M, et al. Selective photocoagulation in Coats' disease: ten-yearfollow-up. Eut J Ophthalmol,2002,12: 501-505.
  • 5张军军,刘谊.曲安奈德玻璃体腔内注射疗法的研究现状[J].中华眼底病杂志,2005,21(4):203-204. 被引量:32
  • 6Antonetti DA, Wolpert EB, Demaio L, et al. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation edoccluding. J Neurechem,2002,80:667-667.
  • 7Yoshizumi MO, Kieiger AE, Lewis H, et al. Vitrectomy techniques in Coats'like exudative retial detachment, Doc Ophthalmol, 1995,90 : 387 -394.
  • 8Chisholm IA, Foulds Ws. Christison D. Ivestigation and therapy of Coats'disease. Trans Ophthalmol Soc UK, 1974,94:335-341.
  • 9Ridley ME. Shields JA, Brown GC, et al. Coats' disease: Evaluation of management. Ophthalmology, 1982,89 : 1381-1387.
  • 10Young S, Larkcin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cysoid macular oedema in uveitis. Clin Experiment ophthalmol,2001,29 :2-6.

二级参考文献13

  • 1刘谊,严密,罗成仁,张军军,杨兰芬.血浆/血球分离荧光形态与Coats病[J].中华眼底病杂志,1995,11(2):74-76. 被引量:1
  • 2Black RL, Oglesby RB, von Sallman L, et al. Posterior subcapsular cataracts induced by corticoids in patients with rheumatoid arthritis. JAMA, 1960,174: 166-171.
  • 3Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol. , 2000,105: 912-916.
  • 4Bettmann JW, Fund WE, Webster RG, et al. Cataractogenic effect of corticosteroids on animals. Am J Ophthalmol, 1967,63:841-844.
  • 5Kivilcim M, Peyman GA, E1-Dessouky ES, et al. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers, 2000,31: 474-478.
  • 6Gillies M, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone. results from a randomized clinical trial. Arch Ophthalmol , 2004,22: 336-340.
  • 7Mccuun BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol , 1981,91: 785-788.
  • 8Gopal L, Bhende M, Sharma T. Vitrectomy for accidental intraocular steroid injection. Retina, 1995,15: 295-299.
  • 9Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy.Am J Ophthalmol , 2003,135:243-246.
  • 10Hida T, Chandler D, Arena JE, et al. Experimental and clinical bservations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol, 1986,101 : 190-195.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部